Communicable disease threats report, 19-25 September, week 39
September 26, 2026
Evaluation of the SARS-CoV-2 testing policy in Belgium from June to December 2021
The aim of this report is to independently evaluate the Belgian SARS-CoV testing policy to support an optimal and sustainable testing policy for public health purposes.
Communicable disease threats report, 6-12 February 2022, week 6
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-12 February 2022, and includes updates on COVID-19, Influenza, Lassa fever, mass gathering monitoring for the Winter Olympic Games in Beijing, Chikungunya, and dengue.
Considerations for the use of antibody tests for SARS-CoV-2 – first update
This report is the first update of a brief technical note that was developed at the request of the European Commission to inform the discussion on Digital Green Certificates to facilitate the safe and free movement of citizens within the EU during the COVID-19 pandemic.
14-day notification rate weighted by vaccine uptake, updated 10 February 2022
Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU.
14-day notification rate weighted by vaccine uptake, updated 10 February 2022 (colour-blind friendly)
Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU.
COVID-19 vaccine effectiveness in adolescents aged 12–17 years and interim public health considerations for administration of a booster dose
The purpose of this document is to review the evidence of COVID-19 vaccine effectiveness and duration of immunity following vaccination in adolescents aged 12-17 years, and to outline interim public health considerations for the potential use of a booster dose in this group.
COVID-19 vaccines for adolescents offer a very high level of protection against infection, symptomatic disease, and severe disease
As of 30 January 2022, 70.9% of adolescents aged 15-17 years and 34.8% of 10-14 year-olds completed the primary course of COVID-19 vaccination, though with a broad range across EU/EEA countries. More than half of adolescents aged 10 to 17 in the EU/EEA have not yet completed a primary course.
Considerations for the use of face masks in the community in the context of the SARS-CoV-2 Omicron variant of concern
This document provides an update to and complements the ECDC technical report on “Using face masks in the community: first update – Effectiveness in reducing transmission of COVID-19” published on 15 February 2021.
ECDC publishes updated considerations for use of face masks in the community
ECDC publishes ‘Considerations for the use of face masks in the community in the context of the SARS-CoV-2 Omicron variant of concern’, a document which updates and complements ‘Using face masks in the community: first update – Effectiveness in reducing transmission of COVID-19’.
E-learning: Understanding vaccine acceptance & strategies to increase vaccine uptake
This e-learning course aims at increasing understanding of the drivers and barriers of vaccine acceptance. You will learn how to design targeted strategies to increase vaccine uptake through behaviour change.
